What is InSteps?
InSteps operates at the intersection of medical technology and computational science, providing specialized in-silico solutions that accelerate the development of life-saving thrombectomy devices. The company's core platform serves as a sophisticated engine for clinical trial optimization, allowing researchers to simulate treatment outcomes with high precision. By integrating real-world data into its predictive models, InSteps addresses the urgent medical necessity for faster, more effective stroke therapies. The firm's value proposition is centered on reducing the time-to-market for medical device manufacturers, offering a robust framework that supports regulatory evidence generation and enhances overall clinical efficacy in the stroke treatment landscape.
How much funding has InSteps raised?
InSteps has raised a total of $512K across 1 funding round:
Debt
$512K
Debt (2026): $512K with participation from Innovatiefonds Noord-Holland
Key Investors in InSteps
Innovatiefonds Noord-Holland
Innovatiefonds Noord-Holland is a regional investment vehicle dedicated to fostering innovation and operational efficiency by supporting high-growth technology companies with accessible digital infrastructure and strategic capital.
What's next for InSteps?
With this major enterprise-level funding, InSteps is poised to accelerate its product roadmap and expand its footprint within the global healthtech ecosystem. The strategic allocation of this capital will likely focus on enhancing the platform's simulation fidelity and broadening its application to additional neurovascular therapeutic areas. As the company transitions into its next phase of growth, the focus will remain on strengthening partnerships with clinical researchers and regulatory bodies to ensure that its in-silico evidence becomes a standard component of the device approval process. By bridging the gap between computational modeling and clinical reality, InSteps is well-positioned to drive significant improvements in patient outcomes while maintaining a competitive edge in the medical device innovation sector.
See full InSteps company page
